# Sethera Therapeutics, Inc — Form D

Sethera Therapeutics, Inc of SALT LAKE CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-30. The offering totals $3.0M, of which $1.9M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-10-30
- Form: D
- Accession: 0002042692-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.9M
- Remaining: $1.1M
- Investors: 21
- Date of first sale: 2024-10-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-528211

## Issuer

- Name: Sethera Therapeutics, Inc
- CIK: 0002042692
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 48 SOUTH RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
- Phone: 801-850-4367

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Vahe Bandarian | Director | Salt Lake City, UT |
| Karsten Eastman | Director | Salt Lake City, UT |
| Cynthia Tsai | Director | Halethorpe, MD |
| Vahe Bandarian | Executive Officer | Salt Lake City, UT |
| Karsten Eastman | Executive Officer | Salt Lake City, UT |
| Yakov Kogan | Executive Officer | Salt Lake City, UT |
| Cynthia Tsai | Executive Officer | Halethorpe, MD |

## More

- [CIK 2042692 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2042692&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002042692-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.